Exercise and insulin-like growth factor 1 supplementation improve angiogenesis and angiogenic cytokines in a rat model of diabetes-induced neuropathy
- 30 April 2020
- journal article
- research article
- Published by Wiley in Experimental Physiology
- Vol. 105 (5), 783-792
- https://doi.org/10.1113/EP088069
Abstract
New Findings What is the central question of this study? Do changes in levels of angiogenesis-related mediators [vascular endothelial growth factor-A (VEGF-A), thrombospondin-1 (TSP-1) and nuclear factor-kappa B (NF-kappa B)] in the sciatic nerve mediate diabetic neuropathy in the streptozotocin-induced type 1 diabetic male rat? Can exercise and insulin-like growth factor 1 (IGF-I) treatment improve the diabetes-related decrease in angiogenesis in sciatic nerve in these animals? What is the main finding and its importance? Levels of VEGF-A, TSP-1 and NF-kappa B change in the sciatic nerve of diabetic rats and might mediate diabetic neuropathy. Treatment with IGF-I and exercise could increase angiogenesis in the diabetic rats by increasing VEGF-A and decreasing TSP-1 and NF-kappa B expression in the sciatic nerve. Diabetic neuropathy is a severe complication of diabetes that affects 40-50% of diabetic people in the world. The aim of this study was to characterize alterations in angiogenesis and related molecular mediators in the sciatic nerve in diabetic conditions alone or in diabetes in combination with exercise and/or administration of insulin-like growth factor 1 (IGF-I). Forty male Wistar rats were assigned into one of five groups, namely control, diabetes, diabetes + exercise, diabetes + IGF-I and diabetes + exercise + IGF-I. Type 1 diabetes was induced by i.p. injection of streptozotocin (60 mg kg(-1)). After 30 days of treatment with exercise or IGF-I alone or in combination, diabetic neuropathy was evaluated with a hotplate, glycated haemoglobin was measured, angiogenesis was determined by immunostaining for PECAM-1/CD31, and expressions of vascular endothelial growth factor-A (VEGF-A), thrombospondin-1 (TSP-1) and nuclear factor-kappa B (NF-kappa B) were determined by enzyme-linked immunosorbent assay.After 4 weeks, the diabetes group showed a significant decrease in capillary density and VEGF-A levels, but a significant increase in glycated haemoglobin in blood, TSP-1 and NF-kappa B levels in the sciatic nerve compared with the control group, and these effects were ameliorated by exercise and IGF-I. However, simultaneous treatment of diabetic rats with IGF-I and exercise did not have any synergistic effects. These findings indicate that diabetes-induced neuropathy may be associated, in part, with decreased angiogenesis mediated by overproduction of TSP-1 and NF-kappa B, in addition to reduced production of VEGF-A. The findings also showed that exercise and IGF-I can reduce neuropathy, followed by increased angiogenesis, by changes in TSP-1, NF-kappa B and VEGF-A production levels.This publication has 46 references indexed in Scilit:
- Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrierMolecular Neurodegeneration, 2013
- Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2Cold Spring Harbor Perspectives in Medicine, 2012
- Oxidative stress, insulin signaling, and diabetesFree Radical Biology & Medicine, 2011
- Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic damMolecular Nutrition & Food Research, 2011
- Insulin-Like Growth Factor-1 (IGF-1) Reduces ischemic changes and increases circulating angiogenic factors in experimentally - induced myocardial infarction in ratsVascular Cell, 2011
- Molecular Mediators of AngiogenesisJournal of Burn Care & Research, 2010
- Bone Marrow Mononuclear Cells Have Neurovascular Tropism and Improve Diabetic NeuropathyThe International Journal of Cell Cloning, 2009
- NF-κB: a new player in angiostatic therapyAngiogenesis, 2008
- Anti-angiogenic peptides identified in thrombospondin type I domainsBiochemical and Biophysical Research Communications, 2007
- Oxidative Stress and Diabetic RetinopathyExperimental Diabetes Research, 2007